Related Experiment Video
Updated: Jul 13, 2026
10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Intrathecal opioids for intractable pain syndromes
A Koulousakis1, J Kuchta, A Bayarassou
1Department of Neurosurgery, Cologne University, Cologne, Germany.
Acta Neurochirurgica. Supplement
|August 19, 2007
Summary
Intrathecal opioid pumps offer effective pain relief for selected patients with chronic non-malignant pain, significantly reducing systemic side effects. This method provides long-term benefits and improves quality of life when other treatments fail.
Area of Science:
- Pain Management
- Neurosurgery
- Pharmacology
Background:
- Intrathecal opioid application via implantable pumps has been an option for over 20 years for managing malignant and non-malignant pain.
- Systemic side effects of oral or intravenous opioids often limit their effectiveness as sole treatments.
- Various non-malignant pain conditions, including failed back syndrome and neuropathic pain, may indicate intrathecal drug delivery.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of intrathecal opioid application for non-malignant pain.
- To assess the impact on pain reduction and quality of life in patients with chronic pain conditions.
- To identify the incidence of technical complications and drug-related side effects associated with intrathecal pumps.
Main Methods:
- Retrospective analysis of patients receiving intrathecal opioid therapy with implantable pumps.
- Pain assessment using the Visual Analogue Scale (VAS) over a follow-up period exceeding 3 years.
- Monitoring of catheter-related issues, pump malfunctions, and drug-specific side effects.
Main Results:
- Over 71% of patients experienced good to excellent pain reduction (>50% decrease on VAS) after 3 years.
- Catheter-related technical problems occurred in 10.3% of patients (17/165).
- Reversible drug-related side effects were observed in 19.4% of patients (32/165), with a low serum/CSF morphine concentration ratio of 1/3000.
Conclusions:
- Intrathecal opioid therapy is a cost-effective and viable option for selected patients with chronic non-malignant pain, significantly improving quality of life.
- Careful catheter placement is crucial for optimal drug distribution and clinical effect.
- Specialized centers and trained personnel are essential for successful implementation and management of intrathecal pump therapy.
Related Concept Videos
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...